Abstract
It was shown that tioconazole possesses an important property not shared by ketoconazole and miconazole, its well-known relatives in the imidazole group of antifungal drugs. At a concentration of 3.8 X 10(-5) M, tioconazole, like miconazole, caused rapid 2- to 3-log reductions in CFU per milliliter when added to late-logarithmic-phase Candida albicans or Candida parapsilosis cells. Only tioconazole, however, exerted similar reductions when added to diluted stationary-phase cultures. This growth-phase-independent lethal action has important clinical implications and may explain the superior performance of tioconazole, which was observed in earlier comparative drug studies.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference15 articles.
1. Physiological states of Candida parapsilosis in relation to miconazole and ketoconazole susceptibilities;Beggs W. H.;IRCS Med. Sci. Libr. Compend.,1983
2. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species;Beggs W. H.;J. Antimicrob. Chemother.,1983
3. The effect of antifungal imidazoles on resting cells of Candida parapsilosis;Beggs W. H.;IRCS Med. Sci. Libr. Compend.,1983
4. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans;Beggs W. H.;Antimicrob. Agents Chemother.,1984
5. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release;Cope J. E.;J. Gen. Microbiol.,1980
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献